Keyphrases
Randomized Double-blind
100%
Erythropoietin
100%
Placebo-controlled Study
100%
Optic Neuritis
100%
Placebo Groups
42%
Peripapillary Retinal Nerve Fiber Layer (pRNFL)
21%
Multiple Sclerosis
14%
Adverse Events
14%
Placebo
14%
Optical Coherence Tomography
14%
Atrophy
14%
Adjusted Means
14%
Treatment Difference
14%
Corticosteroids
14%
Neuroprotection
14%
Low-contrast Letter Acuity
14%
Tertiary Care Hospital
7%
Germany
7%
Ministry of Education
7%
High Dose
7%
Block Size
7%
Headache
7%
Serious Adverse Events
7%
Trial Participants
7%
Visual Acuity
7%
Phase II Trial
7%
Treatment Assignment
7%
Methylprednisolone
7%
Statistician
7%
Phase II Clinical Trial
7%
Loss-to-follow-up
7%
Prospective Randomized Clinical Trial
7%
Block Randomization
7%
Serum Cytokines
7%
Randomized Placebo-controlled Trial
7%
Visual Pathway
7%
Second Primary
7%
Clinically Isolated Syndrome
7%
Anticoagulants
7%
Pharmacist
7%
Sinus Thrombosis
7%
SAS Code
7%
Acuity Score
7%
Revised Diagnosis
7%
One Dose
7%
Medicine and Dentistry
Placebo-Controlled Study
100%
Optic Neuritis
100%
Erythropoietin
100%
Placebo
64%
Adverse Event
21%
Retinal Nerve Fiber Layer
21%
Tomography
14%
Neuroprotection
14%
Cytokine
7%
Clinical Trial
7%
Drug Megadose
7%
Multiple Sclerosis
7%
Clinically Isolated Syndrome
7%
Sequela
7%
Headache
7%
Randomized Clinical Trial
7%
Patient Referral
7%
Visual Acuity
7%
Diagnosis of Multiple Sclerosis
7%
Visual Pathway
7%
Cerebral Sinus Thrombosis
7%
Methylprednisolone
7%
Anticoagulant
7%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo-Controlled Study
100%
Erythropoietin
100%
Optic Neuritis
100%
Placebo
64%
Adverse Event
21%
Neuroprotection
14%
Multiple Sclerosis
14%
Clinical Trial
7%
Randomized Clinical Trial
7%
Cytokine
7%
Headache
7%
Anticoagulant Agent
7%
Demyelinating Disease
7%
Cerebral Sinus Thrombosis
7%
Methylprednisolone
7%
Neuroscience
Erythropoietin
100%
Placebo
100%
Optic Neuritis
100%
Nerve Fiber
21%
Neuroprotection
14%
Multiple Sclerosis
7%
Visual Pathway
7%
Diagnosis of Multiple Sclerosis
7%
Methylprednisolone
7%
Demyelinating Disease
7%
Headache
7%
Immunology and Microbiology
Erythropoietin
100%
Optic Neuritis
100%
Retinal Nerve Fiber Layer
21%
Diagnosis of Multiple Sclerosis
7%
Multiple Sclerosis
7%
Drug Megadose
7%
Visual Acuity
7%
Methylprednisolone
7%
Cytokine
7%
Clinically Isolated Syndrome
7%
Biochemistry, Genetics and Molecular Biology
Erythropoietin
100%
Animal Model
7%
Clinical Trial
7%
Randomized Clinical Trial
7%
Drug Megadose
7%
Visual Acuity
7%
Cytokine
7%
Methylprednisolone
7%